Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Anne Gingery, Emma L Bahe & Jeffrey S Gilbert. (2009) Placental ischemia and breast cancer risk after preeclampsia: tying the knot. Expert Review of Anticancer Therapy 9:5, pages 671-681.
Read now
Read now
Articles from other publishers (16)
Xiuli Wang, Baoshan Zhao, Dan Ren, Xiaolei Hu, Juanjuan Qiao, Dongmei Zhang, Yanzhi Zhang, Yu Pan, Yuhua Fan, Lili Liu, Xiaoxue Wang, Huanhuan Ma, Xueling Jia, Sihang Song, Chong Zhao, Jingbo Liu & Lin Wang. (2023) Pyrimidinergic receptor P2Y6 expression is elevated in lung adenocarcinoma and is associated with poor prognosis. Cancer Biomarkers, pages 1-11.
Crossref
Crossref
Yu Pan, Xiuli Wang, Yanzhi Zhang, Juanjuan Qiao, Hironobu Sasano, Keely McNamara, Baoshan Zhao, Dongmei Zhang, Yuhua Fan, Lili Liu, Xueling Jia, Ming Liu, Sihang Song & Lin Wang. (2020) Estradiol-Induced MMP-9 Expression via PELP1-Mediated Membrane-Initiated Signaling in ERα-Positive Breast Cancer Cells. Hormones and Cancer 11:2, pages 87-96.
Crossref
Crossref
Yulia Liubomirski, Shalom Lerrer, Tsipi Meshel, Linor Rubinstein-Achiasaf, Dina Morein, Stefan Wiemann, Cindy Körner & Adit Ben-Baruch. (2019) Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer. Frontiers in Immunology 10.
Crossref
Crossref
Craig S. Atwood & Samuel F. Ekstein. (2019) Human versus non-human sex steroid use in hormone replacement therapies part 1: Preclinical data. Molecular and Cellular Endocrinology 480, pages 12-35.
Crossref
Crossref
A. A. Smetnik. (2017) MENOPAUSAL HORMONE THERAPY WITH DYDROGESTERONE: ASPECTS OF EFFICACY AND SAFETY OF ULTRA-LOW DOSES. Medical Council:2, pages 92-99.
Crossref
Crossref
E. Fernández-Martínez. 2017. Liver Pathophysiology. Liver Pathophysiology
239
258
.
Tal Leibovich-Rivkin, Yulia Liubomirski, Tsipi Meshel, Anastasia Abashidze, Daphna Brisker, Hilla Solomon, Varda Rotter, Miguel Weil & Adit Ben-Baruch. (2014) The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells. BMC Cancer 14:1.
Crossref
Crossref
Yayun Liang, Cynthia Besch-Williford, Johannes D. Aebi, Benford Mafuvadze, Matthew T. Cook, Xiaoqin Zou & Salman M. Hyder. (2014) Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071. Breast Cancer Research and Treatment 146:1, pages 51-62.
Crossref
Crossref
Tal Leibovich-Rivkin, Yulia Liubomirski, Biana Bernstein, Tsipi Meshel & Adit Ben-Baruch. (2013) Inflammatory Factors of the Tumor Microenvironment Induce Plasticity in Nontransformed Breast Epithelial Cells: EMT, Invasion, and Collapse of Normally Organized Breast Textures. Neoplasia 15:12, pages 1330-IN5.
Crossref
Crossref
Lawrence C. Perlmuter, Garima Sarda, Vanessa Casavant & Aron D. Mosnaim. (2013) A Review of the Etiology, Asssociated Comorbidities, and Treatment of Orthostatic Hypotension. American Journal of Therapeutics 20:3, pages 279-291.
Crossref
Crossref
Tal Leibovich-Rivkin, Yaeli Lebel-Haziv, Shalom Lerrer, Polina Weitzenfeld & Adit Ben-Baruch. 2013. The Tumor Immunoenvironment. The Tumor Immunoenvironment
135
175
.
Adit Ben-Baruch. (2011) The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and Chemokines. Cancer Microenvironment 5:2, pages 151-164.
Crossref
Crossref
Jennifer L. Steiner & E. Angela Murphy. (2018) Importance of chemokine (CC-motif) ligand 2 in breast cancer. The International Journal of Biological Markers 27:3, pages 179-185.
Crossref
Crossref
Gali Soria, Maya Ofri-Shahak, Ilana Haas, Neora Yaal-Hahoshen, Leonor Leider-Trejo, Tal Leibovich-Rivkin, Polina Weitzenfeld, Tsipi Meshel, Esther Shabtai, Mordechai Gutman & Adit Ben-Baruch. (2011) Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer 11:1.
Crossref
Crossref
Alfred O. Mueck, Harald Seeger & Kai-J. Bühling. (2009) Use of dydrogesterone in hormone replacement therapy. Maturitas 65, pages S51-S60.
Crossref
Crossref
Jing Yu, Qian Wu, Shanlei Qiao, Zeping Yu, Nianzu Jin & Boyang Yu. (2009) Simultaneous determination of phytoestrogens and key metabolites in breast cancer patients’ urine by liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 50:5, pages 939-946.
Crossref
Crossref